Current Volume 13(2) 2008 (9)

17 Jun 2008 :
The association between cytokine gene polymorphisms and kidney allograft survival
Andrzej Pawlik, Leszek Domanski
Ann Transplant 2008; 13(2): 54-58 :: ID: 858108
126 1

17 Jun 2008 :
The association between cytokine gene polymorphisms and kidney allograft survival
Andrzej Pawlik, Leszek Domanski, Jacek Rozanski, Bogusław Czerny, Zygmunt Juzyszyn, Grażyna Dutkiewicz, Marek Myslak, Maciej Hałasa, Marcin Słojewski, Ewa Dąbrowska-Zamojcin
Ann Transplant 2008; 13(2): 54-58 :: ID: 858108
126 1

17 Jun 2008 :
Sirolimus induced dyslipidemia in tacrolimus based vs. tacrolimus free immunosuppressive regimens in renal transplant recipients
Hakeam A. Hakeam, Ahmed H. Al-Jedai
Ann Transplant 2008; 13(2): 46-53 :: ID: 858107
309 4

17 Jun 2008 :
Sirolimus induced dyslipidemia in tacrolimus based vs. tacrolimus free immunosuppressive regimens in renal transplant recipients
Hakeam A. Hakeam, Ahmed H. Al-Jedai, Syed M. Raza, Khalid Hamawi
Ann Transplant 2008; 13(2): 46-53 :: ID: 858107
309 4

17 Jun 2008 :
Transjugular Intrahepatic Porto-Caval Shunt (TIPS) in treatment of portal hypertension in liver transplant recipiens
Tadeusz Wróblewski, Olgierd Rowiński
Ann Transplant 2008; 13(2): 42-45 :: ID: 858106
148 3

17 Jun 2008 :
Transjugular Intrahepatic Porto-Caval Shunt (TIPS) in treatment of portal hypertension in liver transplant recipiens
Tadeusz Wróblewski, Olgierd Rowiński, Jerzy Żurakowski, Bogna Ziarkiewicz-Wróblewska, Krzysztof Zieniewicz, Paweł Nyckowski, Marek Krawczyk
Ann Transplant 2008; 13(2): 42-45 :: ID: 858106
148 3

17 Jun 2008 :
Non-resectable hepatic tumors in children – role of liver transplantation
Piotr Kaliciński, Hor Ismail
Ann Transplant 2008; 13(2): 37-41 :: ID: 858105
132 11

17 Jun 2008 :
Non-resectable hepatic tumors in children – role of liver transplantation
Piotr Kaliciński, Hor Ismail, Dorota Broniszczak, Joanna Teisserye, Ludmiła Bacewicz, Małgorzata Markiewicz-Kijewska, Marek Szymczak, Paweł Nachulewicz, Bożenna Dembowska-Bagińska, Przemysław Kluge, Andrzej Kościesza, Adam Kowalski, Marek Stefanowicz, Weronika Kasprzyk, Marek Krawczyk
Ann Transplant 2008; 13(2): 37-41 :: ID: 858105
132 11

17 Jun 2008 :
Human Leukocyte Antigen (HLA) B-27 and older age are associated with augmented cyclosporine blood bioavailability in renal allograft recipients: An attempt toward individualization of immunosuppression
Eghlim Nemati, Saeed Taheri
Ann Transplant 2008; 13(2): 32-36 :: ID: 858104
121 1

17 Jun 2008 :
Human Leukocyte Antigen (HLA) B-27 and older age are associated with augmented cyclosporine blood bioavailability in renal allograft recipients: An attempt toward individualization of immunosuppression
Eghlim Nemati, Saeed Taheri, Vahid Pourfarziani, Behzad Einollahi
Ann Transplant 2008; 13(2): 32-36 :: ID: 858104
121 1

17 Jun 2008 :
Liver transplantation for fulminant Wilson’s disease in children
Małgorzata Markiewicz-Kijewska, Marek Szymczak
Ann Transplant 2008; 13(2): 28-31 :: ID: 858103
123 4

17 Jun 2008 :
Liver transplantation for fulminant Wilson’s disease in children
Małgorzata Markiewicz-Kijewska, Marek Szymczak, Hor Ismail, Sylwester Prokurat, Joanna Teisseyre, Piotr Socha, Irena Jankowska, Anna Chyżyńska, Piotr Kaliciński, Marek Migdał
Ann Transplant 2008; 13(2): 28-31 :: ID: 858103
123 4

17 Jun 2008 :
“Transplantation” research output by Muslim Nations: Current status, trends and future outlook
Mohammad Hossein Nourbala, Saeed Taheri
Ann Transplant 2008; 13(2): 21-27 :: ID: 858102
76 2

17 Jun 2008 :
“Transplantation” research output by Muslim Nations: Current status, trends and future outlook
Mohammad Hossein Nourbala, Saeed Taheri, Ruhollah Habibi, Ehsan Abolhasani, Eghlim Nemati, Vahid Pourfarziani, Shahin Abbaszadeh, Behzad Einollahi
Ann Transplant 2008; 13(2): 21-27 :: ID: 858102
76 2

17 Jun 2008 :
Morphological features and differential diagnosis of hepatitis C recurrence after liver transplantation – literature review and results of single transplantation center
Bogna Ziarkiewicz-Wróblewska, Tadeusz Wróblewski
Ann Transplant 2008; 13(2): 12-20 :: ID: 858101
126 0

17 Jun 2008 :
Morphological features and differential diagnosis of hepatitis C recurrence after liver transplantation – literature review and results of single transplantation center
Bogna Ziarkiewicz-Wróblewska, Tadeusz Wróblewski, Aleksander Wasiutyński
Ann Transplant 2008; 13(2): 12-20 :: ID: 858101
126 0

17 Jun 2008 :
Non invasive assessment of liver fibrosis
Hanni Yeshua, Ran Oren
Ann Transplant 2008; 13(2): 5-11 :: ID: 858100
155 3

17 Jun 2008 :
Non invasive assessment of liver fibrosis
Hanni Yeshua, Ran Oren
Ann Transplant 2008; 13(2): 5-11 :: ID: 858100
155 3
Volume 13(2) 2008 (9) Supplement

01 Dec 2007 :
Drug lymphocyte level: New perspective in clinical immunosuppression monitoring
A. Barbari,
Ann Transplant 2008; 13(1): 43-43 :: ID: 880210
50 0

01 Dec 2007 :
Drug lymphocyte level: New perspective in clinical immunosuppression monitoring
A. Barbari
Ann Transplant 2008; 13(1): 43-43 :: ID: 880210
50 0

01 Dec 2007 :
Comparing graft function for tacrolimus- and cyclosporine-treated patients. A long-term comparative study involving nephrotoxicity markers
Z. Marchewka, J. Kuźniar
Ann Transplant 2008; 13(1): 43-43 :: ID: 880211
42 0

01 Dec 2007 :
Comparing graft function for tacrolimus- and cyclosporine-treated patients. A long-term comparative study involving nephrotoxicity markers
Z. Marchewka, J. Kuźniar, K. Falkiewicz, B. Szymańska, M. Zynek-Litwin, D. Patrzałek, A. Długosz, M. Klinger
Ann Transplant 2008; 13(1): 43-43 :: ID: 880211
42 0

01 Dec 2007 :
Inosine monophosphate dehydrogenase (IMPDH) activity after mycophenolate mofetil (MMF) in renal transplant patients receiving different immunosuppressive combined therapy and stable after at least 3 months’ administration
L. R. Chiarelli, M. Molinaro
Ann Transplant 2008; 13(1): 42-42 :: ID: 880208
36 0

01 Dec 2007 :
Inosine monophosphate dehydrogenase (IMPDH) activity after mycophenolate mofetil (MMF) in renal transplant patients receiving different immunosuppressive combined therapy and stable after at least 3 months’ administration
L. R. Chiarelli, M. Molinaro, C. Libetta, C. Tinelli, L. Cosmai, G. Valentini, A. Dal Canton, M. Regazzi
Ann Transplant 2008; 13(1): 42-42 :: ID: 880208
36 0

01 Dec 2007 :
Biomarkers assays for T-lymphocyte activation and proliferation applied in a multicenter clinical trial of AEB071 in renal transplantation
J. M. Kovarik, K. Budde
Ann Transplant 2008; 13(1): 42-42 :: ID: 880209
56 0

01 Dec 2007 :
Biomarkers assays for T-lymphocyte activation and proliferation applied in a multicenter clinical trial of AEB071 in renal transplantation
J. M. Kovarik, K. Budde, J. Steiger, J. M. Grinyo, F. Straube, A. Groenewegen, A. Vitalit, J. Geissler, J. Klupp, M. J. Barten
Ann Transplant 2008; 13(1): 42-42 :: ID: 880209
56 0

01 Dec 2007 :
Association between pharmacodynamic parameters and clinical events under therapy with EC-MPS in the early phase after kidney transplantation (KTx)
E. Wieland, M. Shipkova
Ann Transplant 2008; 13(1): 41-41 :: ID: 880206
49 0

01 Dec 2007 :
Association between pharmacodynamic parameters and clinical events under therapy with EC-MPS in the early phase after kidney transplantation (KTx)
E. Wieland, M. Shipkova, Y. Martius, G. Hasche, C. Klett, R. Bolley, C. Olbricht
Ann Transplant 2008; 13(1): 41-41 :: ID: 880206
49 0

01 Dec 2007 :
IMPDH activity on day 6 after kidney transplantation is signiï¬cantly related to the risk of acute rejection in MMF treated patients
F. Sombogaard, R.A.A. Mathot
Ann Transplant 2008; 13(1): 41-42 :: ID: 880207
44 0

01 Dec 2007 :
IMPDH activity on day 6 after kidney transplantation is signiï¬cantly related to the risk of acute rejection in MMF treated patients
F. Sombogaard, R.A.A. Mathot, P. Glander, W. Weimar, T. van Gelder
Ann Transplant 2008; 13(1): 41-42 :: ID: 880207
44 0

01 Dec 2007 :
Cyclosporine use in miscellaneous clinical settings other than organ transplantations: is there any evidence for target levels?
H. Tesfaye, R. Prusa
Ann Transplant 2008; 13(1): 40-40 :: ID: 880203
33 0

01 Dec 2007 :
Cyclosporine use in miscellaneous clinical settings other than organ transplantations: is there any evidence for target levels?
H. Tesfaye, R. Prusa, B. Jedlickova, J. Segethova
Ann Transplant 2008; 13(1): 40-40 :: ID: 880203
33 0

01 Dec 2007 :
Pharmacokinetics of mycophenolic acid and its phenyl-glucuronide in kidney transplant recipients with renal insufï¬ciency
M. Chrzanowska, J. Kamińska
Ann Transplant 2008; 13(1): 40-40 :: ID: 880204
32 0

01 Dec 2007 :
Pharmacokinetics of mycophenolic acid and its phenyl-glucuronide in kidney transplant recipients with renal insufï¬ciency
M. Chrzanowska, J. Kamińska, M. Głyda, N. Wachowiak
Ann Transplant 2008; 13(1): 40-40 :: ID: 880204
32 0

01 Dec 2007 :
Tacrolimus – biotechnological prospects for a generic product
W. Gajzlerska, J. Turło
Ann Transplant 2008; 13(1): 40-41 :: ID: 880205
40 0

01 Dec 2007 :
Tacrolimus – biotechnological prospects for a generic product
W. Gajzlerska, J. Turło, B. Gutkowska, F. Herold
Ann Transplant 2008; 13(1): 40-41 :: ID: 880205
40 0

01 Dec 2007 :
Population pharmacokinetics of tacrolimus in paediatric bone marrow transplantation and implementation in a dose adaptation tool
J.E. Wallin, L. E. Friberg
Ann Transplant 2008; 13(1): 39-39 :: ID: 880201
55 0

01 Dec 2007 :
Population pharmacokinetics of tacrolimus in paediatric bone marrow transplantation and implementation in a dose adaptation tool
J.E. Wallin, L. E. Friberg, A. Fasth, C. E. Staatz
Ann Transplant 2008; 13(1): 39-39 :: ID: 880201
55 0

01 Dec 2007 :
Therapeutic Drug Monitoring of tacrolimus in renal transplant patients
B. Solnica, K. Słowińska-Solnica
Ann Transplant 2008; 13(1): 39-40 :: ID: 880202
43 0

01 Dec 2007 :
Therapeutic Drug Monitoring of tacrolimus in renal transplant patients
B. Solnica, K. Słowińska-Solnica, E. Ignacak, J. W. Naskalski
Ann Transplant 2008; 13(1): 39-40 :: ID: 880202
43 0

01 Dec 2007 :
Evaluating co-medication and matrix interference influence on ion yields: A key step in therapeutic drug monitoring HPLC-MS/MS assay validation
C. Seger, M. Bock
Ann Transplant 2008; 13(1): 38-38 :: ID: 880198
46 0

01 Dec 2007 :
Evaluating co-medication and matrix interference influence on ion yields: A key step in therapeutic drug monitoring HPLC-MS/MS assay validation
C. Seger, M. Bock, K. Tentschert, A. Griesmacher
Ann Transplant 2008; 13(1): 38-38 :: ID: 880198
46 0

01 Dec 2007 :
Comparison of tacrolimus levels obtained with twice-daily administration formulation (Prograf®) and with once-daily formulation (Advagraf®)
M. T. Rabuñal Ãlvarez, E. Fernández Gabriel
Ann Transplant 2008; 13(1): 38-38 :: ID: 880199
35 0

01 Dec 2007 :
Comparison of tacrolimus levels obtained with twice-daily administration formulation (Prograf®) and with once-daily formulation (Advagraf®)
M. T. Rabuñal Ãlvarez, E. Fernández Gabriel, M. Outeda MacÃas, I. MartÃn Herranz
Ann Transplant 2008; 13(1): 38-38 :: ID: 880199
35 0

01 Dec 2007 :
Conversion from tacrolimus twice a day formulation to once-daily tacrolimus in kidney transplant recipients
D. Kamińska, M. Kuriata-Kordek
Ann Transplant 2008; 13(1): 38-39 :: ID: 880200
38 0

01 Dec 2007 :
Conversion from tacrolimus twice a day formulation to once-daily tacrolimus in kidney transplant recipients
D. Kamińska, M. Kuriata-Kordek, M. Boratyńska, K. Falkiewicz, M. Klinger
Ann Transplant 2008; 13(1): 38-39 :: ID: 880200
38 0

01 Dec 2007 :
Siemens Healthcare Diagnostics immunosuppressive drug monitoring solutions
T. Wei, N. Morjana
Ann Transplant 2008; 13(1): 37-37 :: ID: 880196
50 0

01 Dec 2007 :
Siemens Healthcare Diagnostics immunosuppressive drug monitoring solutions
T. Wei, N. Morjana, S. Goss, L. Bantum, Y. Yue, R. Janzen, G. Siefring
Ann Transplant 2008; 13(1): 37-37 :: ID: 880196
50 0

01 Dec 2007 :
Evaluation of the Architect and Dimension tacrolimus and cyclosporine assays
P. Wallemacq, J. S. Gofï¬net
Ann Transplant 2008; 13(1): 37-38 :: ID: 880197
66 0

01 Dec 2007 :
Evaluation of the Architect and Dimension tacrolimus and cyclosporine assays
P. Wallemacq, J. S. Gofï¬net, H. Ait-Youcef
Ann Transplant 2008; 13(1): 37-38 :: ID: 880197
66 0

01 Dec 2007 :
Sirolimus measurement by LC-MS/MS without solid phase extraction – overcoming the obstacles
N. W. Brown, P. Arampatzis
Ann Transplant 2008; 13(1): 36-36 :: ID: 880193
62 0

01 Dec 2007 :
Sirolimus measurement by LC-MS/MS without solid phase extraction – overcoming the obstacles
N. W. Brown, P. Arampatzis, C. E. Gonde, M. Pires, J. Tracey, M. Tredger
Ann Transplant 2008; 13(1): 36-36 :: ID: 880193
62 0

01 Dec 2007 :
High throughput LC-MS/MS method for quantitative analysis of immunosuppressant drugs in whole blood using a triple quadrupole LC-MS/MS with an APCI source and implemented on column multiplexing LC system
R. Ruzicka, M. Kozak
Ann Transplant 2008; 13(1): 36-36 :: ID: 880194
38 0

01 Dec 2007 :
High throughput LC-MS/MS method for quantitative analysis of immunosuppressant drugs in whole blood using a triple quadrupole LC-MS/MS with an APCI source and implemented on column multiplexing LC system
R. Ruzicka, M. Kozak, V. Bodepudi, R. Loor, J. Zonderman
Ann Transplant 2008; 13(1): 36-36 :: ID: 880194
38 0

01 Dec 2007 :
Evaluation of a commercially available whole blood calibrator and control kit for the analysis of cyclosporin A, everolimus, sirolimus and tacrolimus using LC/MS/MS technology
A. M. Taylor, T. N. Gamble
Ann Transplant 2008; 13(1): 36-37 :: ID: 880195
45 0

01 Dec 2007 :
Evaluation of a commercially available whole blood calibrator and control kit for the analysis of cyclosporin A, everolimus, sirolimus and tacrolimus using LC/MS/MS technology
A. M. Taylor, T. N. Gamble, D. Blake, T. Drury, M. Ehrdhard
Ann Transplant 2008; 13(1): 36-37 :: ID: 880195
45 0

29 Sep 2008 :
The role of genetics and pharmacogenetic monitoring in transplantation
M. Masri,
Ann Transplant 2008; 13(1): 35-35 :: ID: 880192
42 0

29 Sep 2008 :
The role of genetics and pharmacogenetic monitoring in transplantation
M. Masri
Ann Transplant 2008; 13(1): 35-35 :: ID: 880192
42 0

01 Dec 2007 :
In vivo hepatic CYP3A4 activity is signiï¬cantly higher in tacrolimus treated vs cyclosporine treated renal transplant recipients
H. de Jonge, M. Naesens
Ann Transplant 2008; 13(1): 34-34 :: ID: 880189
36 0

01 Dec 2007 :
In vivo hepatic CYP3A4 activity is signiï¬cantly higher in tacrolimus treated vs cyclosporine treated renal transplant recipients
H. de Jonge, M. Naesens, K. Verbeke, Y. Vanrenterghem, D. R. Kuypers
Ann Transplant 2008; 13(1): 34-34 :: ID: 880189
36 0

01 Dec 2007 :
In vitro investigation of MRP 2 in the cyclosporine A – pravastatin interplay
R.l Kato, M. Nishide
Ann Transplant 2008; 13(1): 34-34 :: ID: 880190
44 0

01 Dec 2007 :
In vitro investigation of MRP 2 in the cyclosporine A – pravastatin interplay
R.l Kato, M. Nishide, C. Kodzu, Y. Ijiri, K. Tanaka
Ann Transplant 2008; 13(1): 34-34 :: ID: 880190
44 0

01 Dec 2007 :
The CYP3A5*1/*3 single nucleotide polymorphism (SNP) determines the extent of drug interaction between tacrolimus and fluconazole in renal transplant recipients
H. de Jonge, M. Naesens
Ann Transplant 2008; 13(1): 34-35 :: ID: 880191
55 0

01 Dec 2007 :
The CYP3A5*1/*3 single nucleotide polymorphism (SNP) determines the extent of drug interaction between tacrolimus and fluconazole in renal transplant recipients
H. de Jonge, M. Naesens, Y. Vanrenterghem, D. R. Kuypers
Ann Transplant 2008; 13(1): 34-35 :: ID: 880191
55 0

01 Dec 2007 :
The pregnane X receptor C-25385t single nucleotide polymorphism (SNP) does not affect tacrolimus pharmacokinetics in a large cohort of renal transplant recipients
H. de Jonge, M. Naesens
Ann Transplant 2008; 13(1): 33-33 :: ID: 880187
41 0

01 Dec 2007 :
The pregnane X receptor C-25385t single nucleotide polymorphism (SNP) does not affect tacrolimus pharmacokinetics in a large cohort of renal transplant recipients
H. de Jonge, M. Naesens, Y. Vanrenterghem, D. R. Kuypers
Ann Transplant 2008; 13(1): 33-33 :: ID: 880187
41 0

01 Dec 2007 :
The effect of CYP3A5 and ABCB1 single nucleotide polymorphisms on tacrolimus dose requirements in caucasian liver transplant patients
A. Provenzani, M. Notarbartolo
Ann Transplant 2008; 13(1): 33-33 :: ID: 880188
44 0

01 Dec 2007 :
The effect of CYP3A5 and ABCB1 single nucleotide polymorphisms on tacrolimus dose requirements in caucasian liver transplant patients
A. Provenzani, M. Notarbartolo, F. Biondi, M. Labbozzetta, P. Poma, G. Vizzini, U. Palazzo, P. Polidori, F. Triolo, B. Gridelli, N. D'Alessandro
Ann Transplant 2008; 13(1): 33-33 :: ID: 880188
44 0

01 Dec 2007 :
Modiï¬ed release formulation in immunotherapy – the tacrolimus case
N. Undre,
Ann Transplant 2008; 13(1): 32-32 :: ID: 880186
48 0

01 Dec 2007 :
Modiï¬ed release formulation in immunotherapy – the tacrolimus case
N. Undre
Ann Transplant 2008; 13(1): 32-32 :: ID: 880186
48 0

01 Dec 2007 :
Generic substitution of immunosuppressive drugs – requirements for an equivalent product
A. Johnston, D. W. Holt
Ann Transplant 2008; 13(1): 31-31 :: ID: 880185
47 0

01 Dec 2007 :
Generic substitution of immunosuppressive drugs – requirements for an equivalent product
A. Johnston, D. W. Holt
Ann Transplant 2008; 13(1): 31-31 :: ID: 880185
47 0

01 Dec 2007 :
Generic products – requirements for drug registration
P. K. Kunicki,
Ann Transplant 2008; 13(1): 30-30 :: ID: 880184
37 0

01 Dec 2007 :
Generic products – requirements for drug registration
P. K. Kunicki
Ann Transplant 2008; 13(1): 30-30 :: ID: 880184
37 0

01 Dec 2007 :
Therapeutic drug monitoring of immunosuppressive drugs – future perspectives
P. Wallemacq,
Ann Transplant 2008; 13(1): 29-29 :: ID: 880183
42 0

01 Dec 2007 :
Therapeutic drug monitoring of immunosuppressive drugs – future perspectives
P. Wallemacq
Ann Transplant 2008; 13(1): 29-29 :: ID: 880183
42 0

01 Dec 2007 :
Influence of interactions between immunosuppressive drugs on therapeutic drug monitoring
D. R. Kuypers,
Ann Transplant 2008; 13(1): 28-28 :: ID: 880182
36 0

01 Dec 2007 :
Influence of interactions between immunosuppressive drugs on therapeutic drug monitoring
D. R. Kuypers
Ann Transplant 2008; 13(1): 28-28 :: ID: 880182
36 0

01 Dec 2007 :
Pharmacokinetics of mycophenolic acid: A comparison between enteric-coated mycophenolate sodium and mycophenolate mofetil in renal transplant recipients
T. van Gelde,
Ann Transplant 2008; 13(1): 27-27 :: ID: 880181
43 0

01 Dec 2007 :
Pharmacokinetics of mycophenolic acid: A comparison between enteric-coated mycophenolate sodium and mycophenolate mofetil in renal transplant recipients
T. van Gelde
Ann Transplant 2008; 13(1): 27-27 :: ID: 880181
43 0

01 Dec 2007 :
Therapeutic drug monitoring of sirolimus and everolimus
E.M. Billaud,
Ann Transplant 2008; 13(1): 26-26 :: ID: 880180
42 0

01 Dec 2007 :
Therapeutic drug monitoring of sirolimus and everolimus
E.M. Billaud
Ann Transplant 2008; 13(1): 26-26 :: ID: 880180
42 0

01 Dec 2007 :
Therapeutic drug monitoring of tacrolimus
P. Wallemacq,
Ann Transplant 2008; 13(1): 25-25 :: ID: 880179
41 0

01 Dec 2007 :
Therapeutic drug monitoring of tacrolimus
P. Wallemacq
Ann Transplant 2008; 13(1): 25-25 :: ID: 880179
41 0

01 Dec 2007 :
Therapeutic drug monitoring of ciclosporin
A. Johnston, D. W. Holt
Ann Transplant 2008; 13(1): 24-24 :: ID: 880178
54 0

01 Dec 2007 :
Therapeutic drug monitoring of ciclosporin
A. Johnston, D. W. Holt
Ann Transplant 2008; 13(1): 24-24 :: ID: 880178
54 0

01 Dec 2007 :
Development of a predictive limited sampling strategy for estimation of mycophenolic acid area under the curve in patients receiving concomitant sirolimus or cyclosporine
L. M. Shaw, M. Figurski
Ann Transplant 2008; 13(1): 23-23 :: ID: 880177
47 0

01 Dec 2007 :
Development of a predictive limited sampling strategy for estimation of mycophenolic acid area under the curve in patients receiving concomitant sirolimus or cyclosporine
L. M. Shaw, M. Figurski, M. D. Pescovitz
Ann Transplant 2008; 13(1): 23-23 :: ID: 880177
47 0

01 Dec 2007 :
Clinical application of population pharmacokinetic methods developed for immunosuppressive drugs
P. Marquet,
Ann Transplant 2008; 13(1): 22-22 :: ID: 880176
45 0

01 Dec 2007 :
Clinical application of population pharmacokinetic methods developed for immunosuppressive drugs
P. Marquet
Ann Transplant 2008; 13(1): 22-22 :: ID: 880176
45 0

01 Dec 2007 :
What can we learn from proï¬ciency testing of immunosuppressive drug assays?
D. W. Holt, A. Johnston
Ann Transplant 2008; 13(1): 21-21 :: ID: 880175
34 0

01 Dec 2007 :
What can we learn from proï¬ciency testing of immunosuppressive drug assays?
D. W. Holt, A. Johnston
Ann Transplant 2008; 13(1): 21-21 :: ID: 880175
34 0

01 Dec 2007 :
Immunoassays for immunosuppressive drugs – beneï¬ ts and risks
W. Steimer,
Ann Transplant 2008; 13(1): 20-20 :: ID: 880174
47 0

01 Dec 2007 :
Immunoassays for immunosuppressive drugs – beneï¬ ts and risks
W. Steimer
Ann Transplant 2008; 13(1): 20-20 :: ID: 880174
47 0

01 Dec 2007 :
Review of the newest HPLC-MS/MS methods for determination of immunosuppressive drugs in clinical practice
M. Korecka,
Ann Transplant 2008; 13(1): 19-19 :: ID: 880173
39 0

01 Dec 2007 :
Review of the newest HPLC-MS/MS methods for determination of immunosuppressive drugs in clinical practice
M. Korecka
Ann Transplant 2008; 13(1): 19-19 :: ID: 880173
39 0

01 Dec 2007 :
Introduction to high-performance liquid chromatography-tandem mass spectrometry: The gold standard for monitoring immunosuppressive drugs
P. J. Taylor,
Ann Transplant 2008; 13(1): 18-18 :: ID: 880172
47 0

01 Dec 2007 :
Introduction to high-performance liquid chromatography-tandem mass spectrometry: The gold standard for monitoring immunosuppressive drugs
P. J. Taylor
Ann Transplant 2008; 13(1): 18-18 :: ID: 880172
47 0

01 Dec 2007 :
Biomarkers - as an adjunct to immunosuppressive drug monitoring
M. Oellerich,
Ann Transplant 2008; 13(1): 17-17 :: ID: 880171
68 0

01 Dec 2007 :
Biomarkers - as an adjunct to immunosuppressive drug monitoring
M. Oellerich
Ann Transplant 2008; 13(1): 17-17 :: ID: 880171
68 0

01 Dec 2007 :
PK/PD modelling of immunosuppressive agents
E. Wyska,
Ann Transplant 2008; 13(1): 16-16 :: ID: 880170
51 0

01 Dec 2007 :
PK/PD modelling of immunosuppressive agents
E. Wyska
Ann Transplant 2008; 13(1): 16-16 :: ID: 880170
51 0

01 Dec 2007 :
Drug transporters for immunosuppressive agents
I.A.M. MacPhee,
Ann Transplant 2008; 13(1): 15-15 :: ID: 880169
32 0

01 Dec 2007 :
Drug transporters for immunosuppressive agents
I.A.M. MacPhee
Ann Transplant 2008; 13(1): 15-15 :: ID: 880169
32 0

01 Dec 2007 :
Pharmacogenetics in immunotherapy: present knowledge and future perspectives
D. A. Hesselink,
Ann Transplant 2008; 13(1): 13-14 :: ID: 880168
58 0

01 Dec 2007 :
Pharmacogenetics in immunotherapy: present knowledge and future perspectives
D. A. Hesselink
Ann Transplant 2008; 13(1): 13-14 :: ID: 880168
58 0

01 Dec 2007 :
Pharmacokinetic principles of immunosuppressive-drugs
K. Budde, P. Glander
Ann Transplant 2008; 13(1): 12-12 :: ID: 880167
35 0

01 Dec 2007 :
Pharmacokinetic principles of immunosuppressive-drugs
K. Budde, P. Glander
Ann Transplant 2008; 13(1): 12-12 :: ID: 880167
35 0

01 Dec 2007 :
Clinical immunosuppression – current status
M. Klinger,
Ann Transplant 2008; 13(1): 11-11 :: ID: 880166
44 0

01 Dec 2007 :
Clinical immunosuppression – current status
M. Klinger
Ann Transplant 2008; 13(1): 11-11 :: ID: 880166
44 0

01 Dec 2007 :
New insight of immunosuppressive drugs related nephrotoxicity
E. Thervet,
Ann Transplant 2008; 13(1): 10-10 :: ID: 880165
45 0

01 Dec 2007 :
New insight of immunosuppressive drugs related nephrotoxicity
E. Thervet
Ann Transplant 2008; 13(1): 10-10 :: ID: 880165
45 0

01 Dec 2007 :
Organ transplantation in Poland
M. Durlik,
Ann Transplant 2008; 13(1): 9-9 :: ID: 880164
36 0

01 Dec 2007 :
Organ transplantation in Poland
M. Durlik
Ann Transplant 2008; 13(1): 9-9 :: ID: 880164
36 0
SARS-CoV-2/COVID-19
17 June 2022 : Case report
Extrapulmonary Manifestations of SARS-CoV-2: A Report of 3 Cases and a Literature ReviewAnn Transplant In Press; DOI: 10.12659/AOT.935874
12 April 2022 : Letter/Correspondence
Pancreas Allograft Thrombosis as a Post-COVID-19 Complication in a Diabetic Patient After Pancreas Transpla...Ann Transplant 2022; 27:e935863
12 November 2021 : Original article
Coronavirus Disease 2019 (COVID-19) in Solid Organ Transplant Recipients: A Case-Control StudyAnn Transplant 2021; 26:e933152
26 October 2021 : Original article
Safety of Antithymocyte Globulin Use in Kidney Graft Recipients During the COVID-19 PandemicAnn Transplant 2021; 26:e933001
In Press
23 Jun 2022 : Original article
Evaluation of Deceased Donor Kidney Transplantation in the Eurotransplant Senior Program in Comparison to S...Ann Transplant In Press; DOI: 10.12659/AOT.936514
21 Jun 2022 : Case report
Extrapulmonary Manifestations of SARS-CoV-2: A Report of 3 Cases and a Literature ReviewAnn Transplant In Press; DOI: 10.12659/AOT.935874
20 Jun 2022 : Original article
The Association Between Tacrolimus Levels and Hyperkalemia in Allograft Recipients Who Underwent Heart or L...Ann Transplant In Press; DOI: 10.12659/AOT.935607
15 Jun 2022 : Original article
Donor CYP3A5 Expression Decreases Renal Transplantation Outcomes in White Renal Transplant RecipientsAnn Transplant In Press; DOI: 10.12659/AOT.936276
Most Viewed Current Articles
26 Jan 2022 : Review article
Recurrence of Hepatocellular Carcinoma After Liver Transplantation: Risk Factors and Predictive ModelsDOI :10.12659/AOT.934924
Ann Transplant 2022; 27:e934924
29 Dec 2021 : Original article
Efficacy and Safety of Tacrolimus-Based Maintenance Regimens in De Novo Kidney Transplant Recipients: A Sys...DOI :10.12659/AOT.933588
Ann Transplant 2021; 26:e933588
24 Jul 2020 : Review article
Kidney Transplantation in the Times of COVID-19 – A Literature ReviewDOI :10.12659/AOT.925755
Ann Transplant 2020; 25:e925755
15 Mar 2022 : Case report
Combined Liver, Pancreas-Duodenum, and Kidney Transplantation for Patients with Hepatitis B Cirrhosis, Urem...DOI :10.12659/AOT.935860
Ann Transplant 2022; 27:e935860